Latest rheumatoid arthritis Stories
Arthritis, multiple sclerosis and a number of other diseases are driven by inflammation, which is activated by multi-protein structures called inflammasomes.
PORTLAND, Ore., Feb.
-- Major European markets can finally benefit from the availability of Inflectra following the patent expiry of reference product Remicade® (infliximab) LAKE FOREST, Ill., Feb.
CRANBURY, N.J., Feb.
Primary Efficacy Analysis Demonstrates Clinical Equivalence THOUSAND OAKS, Calif., Feb.
BAUDETTE, Minn., Jan. 30, 2015 /PRNewswire/ -- ANI Pharmaceuticals, Inc.
-33% rate of DAS28-CRP remission or low disease activity reported in Phase 2a cohort- MONROVIA, Calif., Jan. 29, 2015 /PRNewswire/ -- Xencor, Inc.
Beverly Hills rheumatologist Dr.
-- First biosimilar from Samsung Bioepis to advance to EMA regulatory review -- INCHEON, South Korea, Jan.